The transgenic soybean event DAS-81419-2 contains genes that encode the Cry1F, Cry1Ac, and PAT proteins. Cry1F and Cry1Ac provide protection against key lepidopteran insect pests, while PAT confers tolerance to the herbicide glufosinate. To satisfy regulatory requirements for the safety evaluation of transgenic crops, studies were conducted in the United States and Brazil to evaluate the nutrient and antinutrient composition of event DAS-81419-2 soybean. On the basis of the results of these studies, event DAS-81419-2 soybean is compositionally equivalent to nontransgenic soybean. This conclusion concurs with numerous other published studies in soybean and other crops where compositional equivalence between the transgenic crop and its nontransgenic comparator has been demonstrated.
■ INTRODUCTION
Soybean event DAS-81419-2 (Conkesta seed) [Conkesta is a registered trademark of The Dow Chemical Company ("DOW") or an affiliated company of Dow] was created via Agrobacterium-mediated transformation and expresses the Cry1Ac, Cry1F, and PAT proteins, which are derived from the Gram-positive bacteria Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies aizawai, and Streptomyces viridochromogenes, respectively. The Cry1Ac and Cry1F proteins provide plant protection against certain lepidopteran insect pests, 1−3 while PAT (used as a selectable marker during the development of event DAS-81419-2 soybean) confers tolerance to the herbicide glufosinate. 4 The protection against key lepidopteran soybean insect pests such as soybean looper (Chrysodeixis includens), velvetbean caterpillar (Anticarsia gemmatalis), fall armyworm (Spodoptera frugiperda), and tobacco budworm (Heliothis virescens) that is provided by the Cry1Ac and Cry1F proteins in event DAS-81419-2 will offer soybean producers an invaluable insect management tool that does not require the use of traditional insecticides to control these pests.
Conventional plant breeding involves a multitude of techniques such as direct plant selections, tissue culture, and mutagenesis, and is often associated with mutations, deletions, insertions, and rearrangements with little or no knowledge of the underlying genetic changes that occurred to achieve the desired trait(s). 5 Transgenesis, unlike conventional breeding, consists of the insertion of a known sequence of DNA at a specific insertion point; hence, desirable traits are achieved through a clearly understood mechanism (often the production of a protein that confers insect protection or herbicide tolerance). 6 The development of transgenic crop plants includes extensive research that is conducted to elucidate the genetic changes that are caused by the transgenesis and to investigate any disruption that might occur in native genes or regulatory elements.
The nondisruptive nature of transgenesis has been demonstrated repeatedly. In 86 published studies that were conducted to assess the composition of transgenic crops, compositional equivalence between the transgenic crop and an appropriate nontransgenic comparator was demonstrated. 7−92 Regardless of this amassed body of scientific evidence, government regulations continue to require the conduct of composition studies as part of the safety evaluation of transgenic crops. 93, 94 Previous composition studies have been conducted with soybean expressing Cry1Ac and PAT, cotton expressing Cry1F, Cry1Ac, and PAT, and corn expressing Cry1F; in each of these studies, compositional equivalence between the transgenic crop and the nontransgenic crop was concluded. 11, 89, 91, 95 The objective of this research was to determine whether the composition of forage and seed from event DAS-81419-2 soybean expressing Cry1Ac, Cry1F, and PAT is equivalent to that of nontransgenic soybean.
The experimental design was a randomized complete block with four replicate plots of each entry at each field site in the U.S. study and three replicate plots of each entry at each field site in the Brazil study. In the U.S. study, plots were four rows wide by 7.6 m long with 6 cm seed spacing and 76 cm row spacing. Each four row plot was separated from adjacent plots by two border rows of a commercially available nontransgenic soybean variety of similar maturity. In the Brazil study, plots were 10 rows wide by 10 m long with 10 cm seed spacing and 50 cm row spacing. In addition to DAS-81419-2 and the isoline, a total of five nontransgenic commercial varieties were used (DSR 75213-72, HiSOY 38C60, IL3503, Porter 75148, and Williams 82) in the U.S. study; three out of the five varieties were chosen at random and planted at each field site. In the Brazil study, the nontransgenic commercial variety CD 215 was planted at both field sites. Standard commercial agronomic practices (e.g., insect and weed control) were implemented at each field site (uniformly across the entire trial) to produce a commercially acceptable crop. Forage and seed samples were collected at the R3 (beginning pod) and R8 (full maturity) growth stages, respectively, and shipped to Covance Laboratories Inc. (Madison, Wisconsin) for compositional analysis. Samples were shipped frozen and were placed in freezer storage at the analytical laboratory where they remained until removal for preparation or analysis.
Compositional Analyses. At Covance Laboratories composition samples were cryogenically ground to a homogeneous state using a blender and liquid nitrogen prior to assay. Analytes in forage samples (9 total) included proximates (moisture, carbohydrates, ash, crude fat, and protein), fiber [acid detergent fiber (ADF) and neutral detergent fiber (NDF)], and minerals (calcium and phosphorus); seed analytes (80 total) included proximates (moisture, carbohydrates, ash, crude fat, and protein), fiber (ADF, NDF, crude fiber, and total dietary fiber), minerals (calcium, copper, iron, magnesium, manganese, phosphorus, potassium, selenium, sodium, and zinc), amino acids (alanine, arginine, aspartic acid, cystine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine), fatty acids (8: 6 (pyridoxine hydrochloride), vitamin B 9 (folic acid), vitamin C (ascorbic acid), tocopherols (α, β, γ, δ, total)], and bioactives (lectin, phytic acid, raffinose, stachyose, trypsin inhibitor, total daidzein equivalent, total genistein equivalent, and total glycitein equivalent). With the exception of crude fiber and selenium, samples were assayed using previously published methods. 23 Crude fiber was determined gravimetrically as the loss on ignition of dried residue remaining after digestion of the samples with 1.25% sulfuric acid and 1.25% sodium hydroxide solutions under specific conditions. Selenium samples were closed-vessel microwave digested with nitric acid (HNO 3 ) and water. After digestion, the solution was brought to a final volume with water. To normalize the organic contribution between samples and standards, a dilution was prepared for analysis that contained methanol. The selenium concentration was determined with Se 78 using an inductively coupled plasma-mass spectrometer (ICP-MS) with a dynamic reaction cell (DRC) by comparing the counts generated by standard solutions.
Statistical Analysis. At Dow AgroSciences, analysis of variance (ANOVA) was conducted across field sites within the U.S. study and within the Brazil study using a mixed model where entry was considered a fixed effect and location, block within location, and locationby-entry were designated as random effects. 96 Paired contrasts were performed between DAS-81419-2 and the isoline using t tests, and a false-discovery rate adjustment was applied to the P-values to account for multiplicity.
97−99 Differences were considered significant at the 95% confidence level. Analytes were excluded from the statistical analysis if more than 50% of the results were less than the limit of 
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Article Table 5 . Statistically significant difference when compared with isoline (P < 0.05).
Article Table 6 . Vitamin Composition of DAS-81419-2 Soybean Seed were excluded from analysis of the U.S. data, and the mineral selenium was excluded from analysis of the Brazil data. The range of values observed in the nontransgenic commercial soybean varieties was included to put any statistically significant differences into context, and ranges for nontransgenic soybean in the literature were also compiled for further reference. 11,20,28,30,35,39,59,85,100−106 ■ RESULTS AND DISCUSSION
The composition of DAS-81419-2 soybean forage and seed was compared with that of the isoline at 10 field sites in the U.S. MO; ▲ = York, NE; ■ = Brunswick, NE; ◆ = Germansville, PA; # = Montividiu, Goiaś; ∼ = Indianoṕolis, Minas Geraís. "Isoline" = nearisogenic nontransgenic line. Note that each nontransgenic commercial variety was included, on average, at only half of the field sites in the U.S. study, so the range of data for these entries is expected to be narrower than that of the isoline and DAS-81419-2 entries, which were present at all 10 sites.
Article and two field sites in Brazil. In addition to DAS-81419-2 and the isoline, the U.S. study included five commercially available nontransgenic soybean varieties, and the Brazil study included one commercially available nontransgenic soybean variety. Composition analytes evaluated in forage (9) included proximates, fiber, and minerals, while analytes evaluated in seed (80) included proximates, fiber, minerals, amino acids, fatty acids, vitamins, antinutrients, and bioactives. Of the 80 seed analytes, 18 were excluded from the statistical analysis of the U.S. and/or Brazil data sets because more than 50% of the results were <LOQ. No statistically significant differences were detected between DAS-81419-2 and the isoline in both the U.S. and Brazil studies in all but one (16:0 palmitic acid) of the analytes included in the statistical analysis (Tables 1−7) . Moreover, mean results for all analytes fell within the ranges observed in nontransgenic commercial reference varieties and/or the ranges of values for nontransgenic soybean in the literature. In the U.S. study only, a statistically significant difference was detected between the isoline and DAS-81419-2 soybean for 16:0 palmitic acid. Although statistically significant, the difference had no meaningful effect on nutritional value; the mean 16:0 palmitic acid content of DAS-81419-2 was only 4.5% higher than that of the isoline, and the entire range of values observed in DAS-81419-2 was encompassed by the range of values reported in the literature for nontransgenic soybean (Table 5 ). Furthermore, a difference for 16:0 palmitic acid was not observed in the Brazil study, where the DAS-81419-2 mean was actually slightly lower than the isoline.
While the composition of isoline and DAS-81419-2 soybean was similar both across and within field sites, results within each entry were highly variable across field sites; ADF and NDF in forage provide examples of this site to site variation (Figure 1 ). The lack of differences between the isoline and DAS-81419-2 coupled with the wide range of results across field sites in these studies indicates that environment has a substantial effect on crop composition and the effect of transgenesis is undetectable, as others have reported. 
■ CONCLUSIONS
On the basis of the absence of meaningful differences between the isoline and DAS-81419-2 soybean in studies that were conducted at multiple field sites in two countries, it is concluded that the composition of DAS-81419-2 soybean forage and seed is equivalent to that of nontransgenic soybean. The conclusion of this study is in concordance with 86 other published studies and over 100 regulatory submissions where compositional equivalence between the transgenic crop and nontransgenic crop was concluded. 110 Collectively, these results indicate that composition studies to detect unintended effects due to transgenesis with traits that are not expected to alter composition are of dubious value in assessing the safety of transgenic crops.
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